{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:11Z","timestamp":1792785011190,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(82301609)"],"award-info":[{"award-number":["(82301609)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["(2022M711666)"],"award-info":[{"award-number":["(2022M711666)"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["(2023M741764)"],"award-info":[{"award-number":["(2023M741764)"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"crossref","award":["(BK20220196)"],"award-info":[{"award-number":["(BK20220196)"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the International Joint Research and Development Project of Nanjing","award":["(202201030)"],"award-info":[{"award-number":["(202201030)"]}]},{"name":"the International Joint Research and Development Project of Nanjing","award":["(202308005)"],"award-info":[{"award-number":["(202308005)"]}]},{"name":"the National Key Research and Development Program of China","award":["(2022YFC2406900)"],"award-info":[{"award-number":["(2022YFC2406900)"]}]},{"name":"the Medical Science and Technology Program of Nanjing","award":["(JQX22006)"],"award-info":[{"award-number":["(JQX22006)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-76058-w","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T11:03:23Z","timestamp":1730459003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["AVE0991 ameliorates dopaminergic neuronal damage in Parkinson\u2019s disease through HOTAIRM1\/miR-223-3p\/\u03b1-synuclein axis"],"prefix":"10.1038","volume":"14","author":[{"given":"Rui","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"76058_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/s1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau, L. M. & Breteler, M. M. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 5, 525\u2013535. https:\/\/doi.org\/10.1016\/s1474-4422(06)70471-9 (2006).","journal-title":"Lancet Neurol."},{"key":"76058_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41401-020-0365-y","volume":"41","author":"Q Mao","year":"2020","unstructured":"Mao, Q., Qin, W. Z., Zhang, A. & Ye, N. Recent advances in dopaminergic strategies for the treatment of Parkinson\u2019s disease. Acta Pharmacol. Sin. 41, 471\u2013482. https:\/\/doi.org\/10.1038\/s41401-020-0365-y (2020).","journal-title":"Acta Pharmacol. Sin"},{"key":"76058_CR3","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/joim.13541","volume":"292","author":"M Hariz","year":"2022","unstructured":"Hariz, M. & Blomstedt, P. Deep brain stimulation for Parkinson\u2019s disease. J. Intern. Med. 292, 764\u2013778. https:\/\/doi.org\/10.1111\/joim.13541 (2022).","journal-title":"J. Intern. Med."},{"key":"76058_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong, M. J. & Okun, M. S. Diagnosis and treatment of Parkinson Disease: A review. Jama. 323, 548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360 (2020).","journal-title":"Jama"},{"key":"76058_CR5","doi-asserted-by":"publisher","unstructured":"Chappell, M. C. The Angiotensin-(1\u20137) Axis: Formation and metabolism pathways. Angiotensin-(1\u20137), 1\u201326  (2019). https:\/\/doi.org\/10.1007\/978-3-030-22696-1_1","DOI":"10.1007\/978-3-030-22696-1_1"},{"key":"76058_CR6","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.1007\/s12035-017-0805-y","volume":"55","author":"MA Costa-Besada","year":"2018","unstructured":"Costa-Besada, M. A. et al. Paracrine and intracrine angiotensin 1\u20137\/Mas receptor Axis in the Substantia Nigra of Rodents, monkeys, and humans. Mol. Neurobiol. 55, 5847\u20135867. https:\/\/doi.org\/10.1007\/s12035-017-0805-y (2018).","journal-title":"Mol. Neurobiol."},{"key":"76058_CR7","doi-asserted-by":"publisher","first-page":"624387","DOI":"10.3389\/fnagi.2021.624387","volume":"13","author":"X Mi","year":"2021","unstructured":"Mi, X. et al. The non-peptide Angiotensin-(1\u20137) mimic AVE 0991 attenuates delayed neurocognitive recovery after laparotomy by reducing neuroinflammation and restoring blood-brain Barrier Integrity in aged rats. Front. Aging Neurosci. 13, 624387. https:\/\/doi.org\/10.3389\/fnagi.2021.624387 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"76058_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejphar.2014.12.007","volume":"748","author":"J Wu","year":"2015","unstructured":"Wu, J., Zhao, D., Wu, S. & Wang, D. Ang-(1\u20137) exerts protective role in blood-brain barrier damage by the balance of TIMP-1\/MMP-9. Eur. J. Pharmacol. 748, 30\u201336. https:\/\/doi.org\/10.1016\/j.ejphar.2014.12.007 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"76058_CR9","doi-asserted-by":"publisher","first-page":"903980","DOI":"10.3389\/fnbeh.2022.903980","volume":"16","author":"RP Bruhns","year":"2022","unstructured":"Bruhns, R. P. et al. Angiotensin-(1\u20137) improves cognitive function and reduces inflammation in mice following mild traumatic brain injury. Front. Behav. Neurosci. 16, 903980. https:\/\/doi.org\/10.3389\/fnbeh.2022.903980 (2022).","journal-title":"Front. Behav. Neurosci."},{"key":"76058_CR10","doi-asserted-by":"publisher","first-page":"113681","DOI":"10.1016\/j.bcp.2019.113681","volume":"171","author":"MA Rabie","year":"2020","unstructured":"Rabie, M. A., Abd El Fattah, M. A., Nassar, N. N., Abdallah, D. M. & El-Abhar, H. S. Correlation between angiotensin 1-7-mediated mas receptor expression with motor improvement, activated STAT3\/SOCS3 cascade, and suppressed HMGB-1\/RAGE\/NF-\u03baB signaling in 6-hydroxydopamine hemiparkinsonian rats. Biochem. Pharmacol. 171, 113681. https:\/\/doi.org\/10.1016\/j.bcp.2019.113681 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"76058_CR11","doi-asserted-by":"publisher","unstructured":"Chappell, M. C. & Al Zayadneh, E. M. Angiotensin-(1\u20137) and the regulation of Anti-fibrotic Signaling pathways. J. Cell. Signal. 2. https:\/\/doi.org\/10.4172\/2576-1471.1000134 (2017).","DOI":"10.4172\/2576-1471.1000134"},{"key":"76058_CR12","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.2147\/jir.S343575","volume":"14","author":"R Duan","year":"2021","unstructured":"Duan, R. et al. Angiotensin-(1\u20137) Analogue AVE0991 modulates astrocyte-mediated Neuroinflammation via lncRNA SNHG14\/miR-223-3p\/NLRP3 pathway and offers neuroprotection in a transgenic mouse model of Alzheimer\u2019s Disease. J. Inflamm. Res. 14, 7007\u20137019. https:\/\/doi.org\/10.2147\/jir.S343575 (2021).","journal-title":"J. Inflamm. Res."},{"key":"76058_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.18632\/aging.101419","volume":"10","author":"T Jiang","year":"2018","unstructured":"Jiang, T. et al. AVE0991, a nonpeptide analogue of Ang-(1\u20137), attenuates aging-related neuroinflammation. Aging (Albany NY). 10, 645\u2013657. https:\/\/doi.org\/10.18632\/aging.101419 (2018).","journal-title":"Aging (Albany NY)"},{"key":"76058_CR14","doi-asserted-by":"publisher","unstructured":"Liu, J., Liu, W., Li, R. & Yang, H. Mitophagy in Parkinson\u2019s Disease: From pathogenesis to treatment. Cells. 8https:\/\/doi.org\/10.3390\/cells8070712 (2019).","DOI":"10.3390\/cells8070712"},{"key":"76058_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi, P. et al. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction. Cell. Death Dis. 14, 176. https:\/\/doi.org\/10.1038\/s41419-023-05672-9 (2023).","journal-title":"Cell. Death Dis."},{"key":"76058_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","volume":"33","author":"LL Venda","year":"2010","unstructured":"Venda, L. L., Cragg, S. J., Buchman, V. L. & Wade-Martins, R. \u03b1-Synuclein and dopamine at the crossroads of Parkinson\u2019s disease. Trends Neurosci. 33, 559\u2013568 (2010).","journal-title":"Trends Neurosci."},{"key":"76058_CR17","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.4103\/1673-5374.324854","volume":"17","author":"Q Gao","year":"2022","unstructured":"Gao, Q. et al. Angiotensin-(1\u20137) reduces \u03b1-synuclein aggregation by enhancing autophagic activity in Parkinson\u2019s disease. Neural Regen Res. 17, 1138\u20131145. https:\/\/doi.org\/10.4103\/1673-5374.324854 (2022).","journal-title":"Neural Regen Res."},{"key":"76058_CR18","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad, K., Khorshid, K., Soleymani Fard, H. R., Ghaffari, S. H. & S. & An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J. Cell. Physiol. 234, 5451\u20135465. https:\/\/doi.org\/10.1002\/jcp.27486 (2019).","journal-title":"J. Cell. Physiol."},{"key":"76058_CR19","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/jcp.28988","volume":"235","author":"B He","year":"2020","unstructured":"He, B., Chen, W., Zeng, J., Tong, W. & Zheng, P. MicroRNA-326 decreases tau phosphorylation and neuron apoptosis through inhibition of the JNK signaling pathway by targeting VAV1 in Alzheimer\u2019s disease. J. Cell. Physiol. 235, 480\u2013493. https:\/\/doi.org\/10.1002\/jcp.28988 (2020).","journal-title":"J. Cell. Physiol."},{"key":"76058_CR20","doi-asserted-by":"publisher","first-page":"114676","DOI":"10.1016\/j.expneurol.2024.114676","volume":"374","author":"F Jin","year":"2024","unstructured":"Jin, F. et al. Mir-96-5p alleviates cerebral ischemia-reperfusion injury in mice by inhibiting pyroptosis via downregulating caspase 1. Exp. Neurol. 374, 114676. https:\/\/doi.org\/10.1016\/j.expneurol.2024.114676 (2024).","journal-title":"Exp. Neurol."},{"key":"76058_CR21","doi-asserted-by":"publisher","first-page":"865139","DOI":"10.3389\/fnins.2022.865139","volume":"16","author":"L Wu","year":"2022","unstructured":"Wu, L. et al. Plasma miR-153 and miR-223 levels as potential biomarkers in Parkinson\u2019s Disease. Front. Neurosci. 16, 865139. https:\/\/doi.org\/10.3389\/fnins.2022.865139 (2022).","journal-title":"Front. Neurosci."},{"key":"76058_CR22","doi-asserted-by":"publisher","first-page":"9393","DOI":"10.1038\/s41598-019-45687-x","volume":"9","author":"R Mancuso","year":"2019","unstructured":"Mancuso, R. et al. Circulatory mir-223-3p discriminates between Parkinson\u2019s and Alzheimer\u2019s patients. Sci. Rep. 9, 9393. https:\/\/doi.org\/10.1038\/s41598-019-45687-x (2019).","journal-title":"Sci. Rep."},{"key":"76058_CR23","doi-asserted-by":"publisher","first-page":"113132","DOI":"10.1016\/j.yexcr.2022.113132","volume":"417","author":"Q Sun","year":"2022","unstructured":"Sun, Q. et al. LncRNA HOTAIR promotes \u03b1-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating mir-221-3p in Parkinson\u2019s disease. Exp. Cell. Res. 417, 113132. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113132 (2022).","journal-title":"Exp. Cell. Res."},{"key":"76058_CR24","doi-asserted-by":"publisher","unstructured":"Wu, Y. Y. & Kuo, H. C. Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases. J. Biomed. Sci. 27https:\/\/doi.org\/10.1186\/s12929-020-00636-z (2020).","DOI":"10.1186\/s12929-020-00636-z"},{"key":"76058_CR25","doi-asserted-by":"publisher","first-page":"118863","DOI":"10.1016\/j.lfs.2020.118863","volume":"266","author":"S Gao","year":"2021","unstructured":"Gao, S. et al. LncRNA AK148321 alleviates neuroinflammation in LPS-stimulated BV2 microglial cell through regulating microRNA-1199-5p\/HSPA5 axis. Life Sci. 266, 118863. https:\/\/doi.org\/10.1016\/j.lfs.2020.118863 (2021).","journal-title":"Life Sci."},{"key":"76058_CR26","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1111\/jcmm.13866","volume":"22","author":"Y Huang","year":"2018","unstructured":"Huang, Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J. Cell. Mol. Med. 22, 5768\u20135775. https:\/\/doi.org\/10.1111\/jcmm.13866 (2018).","journal-title":"J. Cell. Mol. Med."},{"key":"76058_CR27","doi-asserted-by":"publisher","unstructured":"Tang, W. et al. The lncRNA-AK046375 upregulates metallothionein-2 by sequestering mir-491-5p to relieve the brain oxidative stress burden after traumatic brain injury. Oxid. Med. Cell. Longev. 2022(8188404). https:\/\/doi.org\/10.1155\/2022\/8188404 (2022).","DOI":"10.1155\/2022\/8188404"},{"key":"76058_CR28","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1007\/s12035-022-02841-3","volume":"59","author":"S Li","year":"2022","unstructured":"Li, S. et al. LncRNA BIRF promotes brain ischemic tolerance Induced by cerebral ischemic preconditioning through upregulating GLT-1 via sponging miR-330-5p. Mol. Neurobiol. 59, 3996\u20134014. https:\/\/doi.org\/10.1007\/s12035-022-02841-3 (2022).","journal-title":"Mol. Neurobiol."},{"key":"76058_CR29","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3389\/fnins.2019.01320","volume":"13","author":"Y Fan","year":"2019","unstructured":"Fan, Y. et al. Dysregulated long non-coding RNAs in Parkinson\u2019s disease contribute to the apoptosis of human neuroblastoma cells. Front. Neurosci. 13, 1320. https:\/\/doi.org\/10.3389\/fnins.2019.01320 (2019).","journal-title":"Front. Neurosci."},{"key":"76058_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04455-3","author":"X Zuo","year":"2024","unstructured":"Zuo, X. et al. 17\u03b2-Trenbolone exposure enhances muscle activity and exacerbates Parkinson\u2019s disease progression in male mice. Mol. Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04455-3 (2024).","journal-title":"Mol. Neurobiol."},{"key":"76058_CR31","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. Fastp: An ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 34, i884\u2013i890. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560 (2018).","journal-title":"Bioinformatics"},{"key":"76058_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 29, 15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"76058_CR33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"76058_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-024-00746-4","volume":"19","author":"P Wang","year":"2024","unstructured":"Wang, P. et al. Pathological characteristics of axons and alterations of proteomic and lipidomic profiles in midbrain dopaminergic neurodegeneration induced by WDR45-deficiency. Mol. Neurodegener. 19, 62. https:\/\/doi.org\/10.1186\/s13024-024-00746-4 (2024).","journal-title":"Mol. Neurodegener"},{"key":"76058_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12035-022-03086-w","volume":"60","author":"T Huang","year":"2023","unstructured":"Huang, T. et al. Dysregulation of circulatory levels of lncRNAs in Parkinson\u2019s disease. Mol. Neurobiol. 60, 317\u2013328. https:\/\/doi.org\/10.1007\/s12035-022-03086-w (2023).","journal-title":"Mol. Neurobiol."},{"key":"76058_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga, S., Sekiya, H., Kondru, N., Ross, O. A. & Dickson, D. W. Neuropathology and molecular diagnosis of synucleinopathies. Mol. Neurodegener. 16, 83. https:\/\/doi.org\/10.1186\/s13024-021-00501-z (2021).","journal-title":"Mol. Neurodegener"},{"key":"76058_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40478-017-0416-x","volume":"5","author":"CW Ip","year":"2017","unstructured":"Ip, C. W. et al. AAV1\/2-induced overexpression of A53T-\u03b1-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: A new mouse model for Parkinson\u2019s disease. Acta Neuropathol. Commun. 5, 11. https:\/\/doi.org\/10.1186\/s40478-017-0416-x (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"76058_CR38","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1093\/brain\/awac171","volume":"145","author":"L Pan","year":"2022","unstructured":"Pan, L. et al. Tau accelerates \u03b1-synuclein aggregation and spreading in Parkinson\u2019s disease. Brain. 145, 3454\u20133471. https:\/\/doi.org\/10.1093\/brain\/awac171 (2022).","journal-title":"Brain"},{"key":"76058_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/nan.12644","volume":"47","author":"P La Vitola","year":"2021","unstructured":"La Vitola, P. et al. Peripheral inflammation exacerbates \u03b1-synuclein toxicity and neuropathology in Parkinson\u2019s models. Neuropathol. Appl. Neurobiol. 47, 43\u201360. https:\/\/doi.org\/10.1111\/nan.12644 (2021).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"76058_CR40","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smaji\u0107","year":"2022","unstructured":"Smaji\u0107, S. et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain. 145, 964\u2013978. https:\/\/doi.org\/10.1093\/brain\/awab446 (2022).","journal-title":"Brain"},{"key":"76058_CR41","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ejphar.2008.05.024","volume":"590","author":"L Ebermann","year":"2008","unstructured":"Ebermann, L. et al. The angiotensin-(1\u20137) receptor agonist AVE0991 is cardioprotective in diabetic rats. Eur. J. Pharmacol. 590, 276\u2013280. https:\/\/doi.org\/10.1016\/j.ejphar.2008.05.024 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"76058_CR42","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1158\/0008-5472.Can-18-1207","volume":"79","author":"KT Murphy","year":"2019","unstructured":"Murphy, K. T. et al. Mas receptor activation slows Tumor Growth and attenuates muscle wasting in Cancer. Cancer Res. 79, 706\u2013719. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-1207 (2019).","journal-title":"Cancer Res."},{"key":"76058_CR43","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","volume":"185","author":"KD da Silveira","year":"2010","unstructured":"da Silveira, K. D. et al. Anti-inflammatory effects of the activation of the angiotensin-(1\u20137) receptor, MAS, in experimental models of arthritis. J. Immunol. 185, 5569\u20135576. https:\/\/doi.org\/10.4049\/jimmunol.1000314 (2010).","journal-title":"J. Immunol."},{"key":"76058_CR44","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1080\/21655979.2022.2033409","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. LncRNA mir-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p\/alpha-synuclein axis in Parkinson\u2019s disease. Bioengineered. 13, 4493\u20134516. https:\/\/doi.org\/10.1080\/21655979.2022.2033409 (2022).","journal-title":"Bioengineered"},{"key":"76058_CR45","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1523\/jneurosci.3900-15.2016","volume":"36","author":"AD Thome","year":"2016","unstructured":"Thome, A. D., Harms, A. S., Volpicelli-Daley, L. A. & Standaert, D. G. microRNA-155 regulates Alpha-Synuclein-Induced inflammatory responses in models of Parkinson Disease. J. Neurosci. 36, 2383\u20132390. https:\/\/doi.org\/10.1523\/jneurosci.3900-15.2016 (2016).","journal-title":"J. Neurosci."},{"key":"76058_CR46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fnmol.2017.00329","volume":"10","author":"E Valera","year":"2017","unstructured":"Valera, E. et al. MicroRNA-101 modulates autophagy and oligodendroglial alpha-synuclein accumulation in multiple system atrophy. Front. Mol. Neurosci. 10, 329. https:\/\/doi.org\/10.3389\/fnmol.2017.00329 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"76058_CR47","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41419-022-04934-2","volume":"13","author":"Q Liu","year":"2022","unstructured":"Liu, Q. et al. circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p\/\u03b1-syn pathway in Parkinson\u2019s disease. Cell. Death Dis. 13, 477. https:\/\/doi.org\/10.1038\/s41419-022-04934-2 (2022).","journal-title":"Cell. Death Dis."},{"key":"76058_CR48","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.biopsych.2018.12.008","volume":"85","author":"Y Su","year":"2019","unstructured":"Su, Y. et al. MicroRNA-26a\/death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in Parkinson\u2019s disease. Biol. Psychiatry. 85, 769\u2013781. https:\/\/doi.org\/10.1016\/j.biopsych.2018.12.008 (2019).","journal-title":"Biol. Psychiatry"},{"key":"76058_CR49","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1007\/s10072-021-05408-7","volume":"42","author":"E Taghizadeh","year":"2021","unstructured":"Taghizadeh, E. et al. LncRNAs as putative biomarkers and therapeutic targets for Parkinson\u2019s disease. Neurol. Sci. 42, 4007\u20134015. https:\/\/doi.org\/10.1007\/s10072-021-05408-7 (2021).","journal-title":"Neurol. Sci."},{"key":"76058_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.brainresbull.2020.02.003","volume":"157","author":"Y Fan","year":"2020","unstructured":"Fan, Y., Zhao, X., Lu, K. & Cheng, G. LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson\u2019s disease via ablating microRNA-125b-5p. Brain Res. Bull. 157, 119\u2013127. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.02.003 (2020).","journal-title":"Brain Res. Bull."},{"key":"76058_CR51","doi-asserted-by":"publisher","first-page":"111614","DOI":"10.1016\/j.yexcr.2019.111614","volume":"384","author":"C Qian","year":"2019","unstructured":"Qian, C. et al. Downregulated lncRNA-SNHG1 enhances autophagy and prevents cell death through the miR-221\/222 \/p27\/mTOR pathway in Parkinson\u2019s disease. Exp. Cell. Res. 384, 111614. https:\/\/doi.org\/10.1016\/j.yexcr.2019.111614 (2019).","journal-title":"Exp. Cell. Res."},{"key":"76058_CR52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello, L., Guo, C. J., Chen, L. L. & Huarte, M. Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell. Biol. 22, 96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9 (2021).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"76058_CR53","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-019-1097-9","volume":"18","author":"YP Hu","year":"2019","unstructured":"Hu, Y. P. et al. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p\/SET\/AKT axis. Mol. Cancer. 18, 167. https:\/\/doi.org\/10.1186\/s12943-019-1097-9 (2019).","journal-title":"Mol. Cancer"},{"key":"76058_CR54","doi-asserted-by":"publisher","unstructured":"Bridges, M. C., Daulagala, A. C. & Kourtidis, A. LNCcation: lncRNA localization and function. J. Cell. Biol. 220 https:\/\/doi.org\/10.1083\/jcb.202009045 (2021).","DOI":"10.1083\/jcb.202009045"},{"key":"76058_CR55","doi-asserted-by":"publisher","unstructured":"Zheng, Y. L. et al. LINC01554-mediated glucose metabolism reprogramming suppresses tumorigenicity in hepatocellular carcinoma via downregulating PKM2 expression and inhibiting Akt\/mTOR signaling pathway. Theranostics 9, 796\u2013810 (2019). https:\/\/doi.org\/10.7150\/thno.28992","DOI":"10.7150\/thno.28992"},{"key":"76058_CR56","doi-asserted-by":"publisher","first-page":"165957","DOI":"10.1016\/j.bbadis.2020.165957","volume":"1867","author":"G Shi","year":"2021","unstructured":"Shi, G. et al. Long non-coding RNA LINC00511\/miR-150\/MMP13 axis promotes breast cancer proliferation, migration and invasion. Biochim. Biophys. Acta Mol. Basis Dis. 1867, 165957. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165957 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76058-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76058-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76058-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T11:05:32Z","timestamp":1730459132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76058-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["76058"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-76058-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4723150\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26346"}}